Recombinant anti-EGFr antibody

Anti-EGFR antibody · Sichuan Kelun Pharmaceutical Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Recombinant anti-EGFr antibody, covering 2017-01-11 to 2017-01-11. Get the full timeline:

Most recent: Clinical Trial Update: Safety and Pharmacokinetics of Recombinant Anti-EGFr Antibody in Patients With Metastatic Colorectal Cancer [Phase 1]

See pricing